These nonspecific symptoms often make Pompe disease clinically difficult to differentiate from other neuromuscular diseases, but valuable evidence can be provided by measurement of decreased GAA activity, observations of vacuoles in muscle fibers on muscle biopsy, and genetic tests of the GAA gene [3,4]. Here, GAA is linked to glycogen storage disease II.